An importing industry of national priority
The pharmaceutical industry in Mexico accounts for a significant share of the country’s economy, bringing in more than 76 billion Mexican pesos in 2020. With a production value of nearly 160 billion Mexican pesos that same year, the pharmaceutical market employed over 54 thousand people in total. Despite its significant role in the national economy, Mexico’s pharma industry relies mostly on imports. Together, the United States and Germany accounted for nearly half of the total imports. Additionally, medications consisting of mixed or unmixed products for therapeutic or prophylactic uses gathered almost two thirds of this value.COVID-19 vaccine marathon
More than 1.5 thousand drugs and vaccines targeting the coronavirus (COVID-19) disease were in development worldwide as of June 2022. The number goes down to 59 clinical studies completed in Mexico, hoping to find a cure to the pandemic that has threatened millions of lives. With 39 candidates already launched, countries all over the world had started negotiations and acquisition of the different vaccines, along with immunization campaigns that have allowed more than 12 billion doses to be administered. Thus, clinical studies remain relevant for the pharmaceutical industry. A higher spending on research and development will speed up the process of new drugs becoming available on the market, not only in the case of pandemics, but also to fight diseases that have continuously burden global public health for decades.
